search
Back to results

Combination Trial of Intravenous Paracetamol - Morphine for Treating Acute Renal Colic in Emergency Setting: An Optimum Treatment

Primary Purpose

Renal Colic

Status
Completed
Phase
Phase 4
Locations
Study Type
Interventional
Intervention
Paracetamol+Morphine
Dexketoprofen plus Morphine
Placebo plus Morphine
Sponsored by
Akdeniz University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Renal Colic

Eligibility Criteria

18 Years - 55 Years (Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria: Renal colic patients -

Exclusion Criteria: Not renal colic patients

-

Sites / Locations

    Arms of the Study

    Arm 1

    Arm 2

    Arm 3

    Arm Type

    Placebo Comparator

    Active Comparator

    Active Comparator

    Arm Label

    Placebo

    Paracetamol

    Dexketoprofene

    Arm Description

    Outcomes

    Primary Outcome Measures

    pain reductions in VAS scores during the 60th and 90th minutes

    Secondary Outcome Measures

    Need for rescue analgesic

    Full Information

    First Posted
    March 4, 2019
    Last Updated
    March 5, 2019
    Sponsor
    Akdeniz University
    search

    1. Study Identification

    Unique Protocol Identification Number
    NCT03865004
    Brief Title
    Combination Trial of Intravenous Paracetamol - Morphine for Treating Acute Renal Colic in Emergency Setting: An Optimum Treatment
    Official Title
    Paracetamol Plus Morphine in ED
    Study Type
    Interventional

    2. Study Status

    Record Verification Date
    March 2019
    Overall Recruitment Status
    Completed
    Study Start Date
    October 17, 2015 (Actual)
    Primary Completion Date
    October 17, 2016 (Actual)
    Study Completion Date
    October 17, 2018 (Actual)

    3. Sponsor/Collaborators

    Responsible Party, by Official Title
    Sponsor
    Name of the Sponsor
    Akdeniz University

    4. Oversight

    Studies a U.S. FDA-regulated Drug Product
    No
    Studies a U.S. FDA-regulated Device Product
    No
    Data Monitoring Committee
    No

    5. Study Description

    Brief Summary
    This randomized, placebo-controlled trial evaluated the analgesic efficacy and safety of intravenous morphine-paracetamol combination and morphine-dexketoprofen combination morphine for the optimum treatment of renal colic. Combination of IV morphine and paracetamol is as effective and rapid as combination of IV Morphine and IV dexketoprophen for optimum treating of renal colic.

    6. Conditions and Keywords

    Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
    Renal Colic

    7. Study Design

    Primary Purpose
    Treatment
    Study Phase
    Phase 4
    Interventional Study Model
    Parallel Assignment
    Masking
    Participant
    Allocation
    Randomized
    Enrollment
    136 (Actual)

    8. Arms, Groups, and Interventions

    Arm Title
    Placebo
    Arm Type
    Placebo Comparator
    Arm Title
    Paracetamol
    Arm Type
    Active Comparator
    Arm Title
    Dexketoprofene
    Arm Type
    Active Comparator
    Intervention Type
    Drug
    Intervention Name(s)
    Paracetamol+Morphine
    Other Intervention Name(s)
    Parol
    Intervention Description
    1gr paracetamol plus 0.1 mg/kg morphine were performed simultanously
    Intervention Type
    Drug
    Intervention Name(s)
    Dexketoprofen plus Morphine
    Other Intervention Name(s)
    Arveles
    Intervention Description
    Intravenous 75 mg Dexketoprofen plus 0,1 mg/kg morphine were performed simultanously
    Intervention Type
    Drug
    Intervention Name(s)
    Placebo plus Morphine
    Other Intervention Name(s)
    SF
    Intervention Description
    100 cc NaCl plus 0.1 mg/kg morphine were performed simultanously
    Primary Outcome Measure Information:
    Title
    pain reductions in VAS scores during the 60th and 90th minutes
    Time Frame
    60 minutes
    Secondary Outcome Measure Information:
    Title
    Need for rescue analgesic
    Time Frame
    30 minutes

    10. Eligibility

    Sex
    All
    Minimum Age & Unit of Time
    18 Years
    Maximum Age & Unit of Time
    55 Years
    Accepts Healthy Volunteers
    No
    Eligibility Criteria
    Inclusion Criteria: Renal colic patients - Exclusion Criteria: Not renal colic patients -

    12. IPD Sharing Statement

    Plan to Share IPD
    No

    Learn more about this trial

    Combination Trial of Intravenous Paracetamol - Morphine for Treating Acute Renal Colic in Emergency Setting: An Optimum Treatment

    We'll reach out to this number within 24 hrs